Vapotherm Blog
Who are the key stakeholders in Respiratory Care Department Productivity Systems and How to Leverage them in Advocating for Appropriate Productivity Targets
I’ve covered elsewhere what Productivity is and how to measure it, so here I’ll focus on why it is absolutely critical to identify, educate, and engage all stakeholders in advocating for appropriate productivity targets. By doing so, the RT leader will optimize her chances of successfully implementing a productivity system in their organization that is standardized, validated,
What is the difference between Respiratory Care Department Billing Systems vs Productivity Systems?
Billing and Productivity systems are the backbone allowing Respiratory Departments to demonstrate their financial value and efficiency in performing services. Too often though, they get conflated, where a Billing system serves as the proxy for Productivity—something that should not happen. To better understand the purpose and differences of these two important systems, it helps to understand a
How to Make Sense of Charting, Charging, Costing, Reimbursement, and Productivity—Fundamentals for Respiratory Therapists in Inpatient Settings
For many of us during our respiratory care training, we were taught to focus on clinical documentation, which remains the focus for the bedside Respiratory Therapist (RT). However, we also know that there are important non-clinical aspects of documentation, including charging, billing, and reimbursement with ramifications that have changed over time and are sometimes hard to understand. So, what exactly do these
Velocity – Ep 8 – Respiratory Directors Share COVID-19 Experiences
Episode 8: (Part 2) Respiratory Directors Share COVID-19 Experiences Respiratory Department leaders Shelly Brown from Arkansas, Vernon Druses from New York, and Lenny Nyangwara from Maryland, continue their COVID-19 conversation from our last episode. Here they touch on relevant issues such as how they’ve dealt with supply shortages including PPE, and what COVID-19 advice they
[FELIX-1 White Paper] – Computational Fluid Dynamic Modelling of Particle Capture: Possible Use of a Modified Face-Tent as a Facial Scavenger
Scott Leonard, BSME1; George C. Dungan II, MPhil(Med)1,2,3 1Vapotherm, Inc. Exeter, NH, USA; 2NHMRC Centre for Integrated Research and Understanding of Sleep-CIRUS, Australia; 3Education and Human Services, Canisius College, Buffalo, NY USA. ABSTRACT Aerosol generating procedures (AGPs) present a substantial clinical challenge during any clinical interaction, much less during a global viral pandemic. Control of
FELIX-1: Creating a Localized Area of Negative Pressure for COVID-19 Patients
Even before COVID-19 became a truly global pandemic, it became clear that protecting healthcare workers (HCWs) from infection was crucial. Many major health organizations, like the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO)1, and the Society of Critical Care Medicine (SCCM)2 put out guidance to include the use of high
Velocity – Ep 7 – Respiratory Directors Share COVID-19 Experiences
Episode 7: Respiratory Directors Share COVID-19 Experiences Shelly Brown from Arkansas, Vernon Druses from New York, and Lenny Nyangwara from Maryland are all Respiratory Department leaders.They share their experiences on how the coronavirus pandemic has impacted their hospitals and clinical practice and discuss treating the respiratory symptoms associated with COVID-19. Subscribe to Velocity wherever you
Velocity – Ep 6 – An ED Physician and COVID-19 Patient (Part 2)
Episode 6: An ED Physician and COVID-19 Patient (Part 2) Dr. Louis Philip Rotkowitz is an ER doctor out of Queens, NYC. Like so many other health care professionals, he would find himself fighting COVID-19 as a patient. In this episode, Dr. Rotkowitz reflects on his experience in a conversation with fellow ER physician, Dr.
We’re here for you. A COVID-19 update from CEO Joe Army
The pandemic isn’t over. Vapotherm CEO Joe Army brings you to our Exeter, NH headquarters to share what we’ve been up to to best support you and your patients.
Thinking Outside the Mask with COPD
Clinicians familiar with literature on Vapotherm high velocity therapy are already aware that Vapotherm therapy has been clinically proven to be comparable to noninvasive positive pressure ventilation (NiPPV) when treating respiratory distress in spontaneously breathing patients. [1] [2] In a 2018 randomized, controlled, multi-center noninferiority trial, Doshi and colleagues compared the efficacy of a mask-free